Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 118236
Published online Sep 9, 2026. doi: 10.5409/wjcp.118236
Published online Sep 9, 2026. doi: 10.5409/wjcp.118236
Table 1 Participant characteristics (n = 28), n (%)/mean ± SD
| Variable | Value |
| Boys/girls (n) | 17/11 |
| Age (years) | 12.6 ± 4.9 |
| Preadolescent/adolescent | 9/19 |
| Body weight (kg) | 51.8 ± 17.0 |
| Stature (cm) | 157.7 ± 20.5 |
| Duration of T1DM diagnosis (years) | 4.6 ± 4.4 |
| HbA1c (%) | 7.9 ± 2.1 |
| Previously on CSII (other pump) | 25 (89) |
| Blood glucose levels (mg/dL) | 163.1 ± 34.7 |
| Average TDD total daily dose (IU) | 40.4 ± 21.2 |
| Average carbohydrates/day (g/day) | 132.2 ± 76.6 |
- Citation: Kosta K, Grammatikopoulou MG, Toulia I, Smyrnaki P, Paschalidou EG, Vamvakis A, Bogiatzoglou A, Tzimos C, Tsiroukidou K. Patient satisfaction and performance of the A8+ TouchCare Nano in children and adolescents with type 1 diabetes mellitus. World J Clin Pediatr 2026; 15(3): 118236
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/118236.htm
- DOI: https://dx.doi.org/10.5409/wjcp.118236